---
figid: PMC9471422__fimmu-13-968799-g002
figtitle: Contribution of the gut-liver axis to the immune signaling pathway of NAFLD
organisms:
- Escherichia coli
- Clostridioides difficile
- Enterococcus faecalis
- Akkermansia muciniphila
- Lacticaseibacillus rhamnosus
- Escherichia coli SCD1
- Bilophila wadsworthia
- Lentilactobacillus kefiri
- Saccharomyces cerevisiae
- Solanum lycopersicum
- Panax ginseng
- Mus musculus
- Rattus norvegicus
- gut metagenome
- human gut metagenome
- Homo sapiens
- Bos taurus
organisms_ner:
- Bos taurus
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Solanum lycopersicum
- Danio rerio
pmcid: PMC9471422
filename: fimmu-13-968799-g002.jpg
figlink: /pmc/articles/PMC9471422/figure/f2/
number: F2
caption: The destruction of the intestinal epithelial barrier caused by intestinal
  flora imbalance is an important condition for the development of NAFLD and nonalcoholic
  steatohepatitis (NASH). Intestinal inflammation and the production of metabolic
  toxins cause intestinal barrier dysfunction, exposing the liver to flora metabolites
  and promoting the development of NAFLD. BAs, bile acids; CDCA, chenodeoxycholic
  acid; CA, cholic acid; DCA, deoxycholic acid; LCA, lithocholic acid; TMAO, trimethylamine
  oxide; TGR5, Takeda G protein-coupled receptor 5; FGF, fibroblast growth factor;
  SHP, small heterodimer partner; SREBP-lc, sterol regulatory element-binding protein-lc;
  SIRT1, sirtuin 1; PGC-1a, proliferator activated receptor g coactivator 1 a; PPARa,
  peroxisome proliferator activated receptor alpha; GLP, glucagon like peptide; GPR,
  G protein-coupled receptor; TNF, tumor necrosis factor; IL-6, interleukin; NLRP3,
  NOD-like receptor protein 3; LPS, lipopolysaccharide; LBP, lipopolysaccharidebinding
  protein; SIBO, Small intestinal bacterial overgrowth; IPA, Indole-3-propionic acid;
  IAA, 3-Indoleacetic acid; Myd88, myeloid differentiation factor 88; MAPK, mitogen-activated
  protein kinase; NF-kB, nuclear factor kappa-B; NO, nitric oxide; ROS, reactive oxygen
  species; Trp, tryptophan; NAD, nicotinamide adenine dinucleotide; BCAA, branched-chain
  amino acid; mTORC, mammalian target of rapamycin complex; Akt, protein kinase B;
  INSIG2a, insulin induced gene 2a; Foxo1, forkhead box O1; Mul1, mitochondrial E3
  ubiquitin protein ligase 1; RAB1A, member ras oncogene family; Prdx1, peroxiredoxin
  1; Ub, ubiquitin; p-, Phosphorylation.
papertitle: The contribution of the gut-liver axis to the immune signaling pathway
  of NAFLD.
reftext: Jiayi Liu, et al. Front Immunol. 2022;13:968799.
year: '2022'
doi: 10.3389/fimmu.2022.968799
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: NAFLD (nonalcoholic fatty liver disease) | intestinal flora | gut-liver
  axis | Inflammation | lipid metabolism | insulin resistance
automl_pathway: 0.9347091
figid_alias: PMC9471422__F2
figtype: Figure
redirect_from: /figures/PMC9471422__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9471422__fimmu-13-968799-g002.html
  '@type': Dataset
  description: The destruction of the intestinal epithelial barrier caused by intestinal
    flora imbalance is an important condition for the development of NAFLD and nonalcoholic
    steatohepatitis (NASH). Intestinal inflammation and the production of metabolic
    toxins cause intestinal barrier dysfunction, exposing the liver to flora metabolites
    and promoting the development of NAFLD. BAs, bile acids; CDCA, chenodeoxycholic
    acid; CA, cholic acid; DCA, deoxycholic acid; LCA, lithocholic acid; TMAO, trimethylamine
    oxide; TGR5, Takeda G protein-coupled receptor 5; FGF, fibroblast growth factor;
    SHP, small heterodimer partner; SREBP-lc, sterol regulatory element-binding protein-lc;
    SIRT1, sirtuin 1; PGC-1a, proliferator activated receptor g coactivator 1 a; PPARa,
    peroxisome proliferator activated receptor alpha; GLP, glucagon like peptide;
    GPR, G protein-coupled receptor; TNF, tumor necrosis factor; IL-6, interleukin;
    NLRP3, NOD-like receptor protein 3; LPS, lipopolysaccharide; LBP, lipopolysaccharidebinding
    protein; SIBO, Small intestinal bacterial overgrowth; IPA, Indole-3-propionic
    acid; IAA, 3-Indoleacetic acid; Myd88, myeloid differentiation factor 88; MAPK,
    mitogen-activated protein kinase; NF-kB, nuclear factor kappa-B; NO, nitric oxide;
    ROS, reactive oxygen species; Trp, tryptophan; NAD, nicotinamide adenine dinucleotide;
    BCAA, branched-chain amino acid; mTORC, mammalian target of rapamycin complex;
    Akt, protein kinase B; INSIG2a, insulin induced gene 2a; Foxo1, forkhead box O1;
    Mul1, mitochondrial E3 ubiquitin protein ligase 1; RAB1A, member ras oncogene
    family; Prdx1, peroxiredoxin 1; Ub, ubiquitin; p-, Phosphorylation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP7A1
  - FGF19
  - GPBAR1
  - SIRT1
  - PPARA
  - GCG
  - IL10
  - GLP1R
  - FFAR2
  - NLRP3
  - TLR4
  - TNF
  - IL6
  - LBP
  - CD14
  - MYD88
  - IL15
  - RAB1A
  - AKT2
  - MAVS
  - FOXO1
  - PROX1
  - PRDX1
  - Cyp7a1
  - Ptprc
  - Nr1h4
  - Fgf19
  - Nr0b2
  - Gpbar1
  - Sirt1
  - Tmprss5
  - Prkaa2
  - Ppara
  - Clta
  - Gcg
  - Il10
  - Glp1r
  - Hcar2
  - Ffar2
  - Arid4b
  - Nlrp3
  - Tlr4
  - Tnf
  - Il6
  - Lbp
  - Ehhadh
  - Cd14
  - Myd88
  - Nfkb1
  - Il15
  - Adh1c
  - Avp
  - Rab1a
  - Akt2
  - Mavs
  - Elavl2
  - Foxo1
  - Samsn1
  - Prox1
  - Prdx1
  - Kcnk13
  - BAS
  - HLA-DQA2
  - CLTA
  - GUCY2D
  - PTPRC
  - NR1H4
  - NR0B2
  - COL14A1
  - APRT
  - MFAP1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ZGLP1
  - HCAR2
  - ARID4B
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - IRF6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EHHADH
  - RPSA
  - NDUFA2
  - NFKB1
  - AVP
  - ADH1A
  - ADH1B
  - ADH1C
  - ADH4
  - ADH5
  - ADH6
  - ADH7
  - ADHFE1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - ELAVL2
  - RPTOR
  - TRA-TGC7-1
  - Bas
  - Fgf15
  - Tsc2
  - H2-Aa
  - hubb
  - Nprl3
  - LCA1
  - ADH
  - Rab1A
  - cyp7a1
  - fxr
  - fgf19
  - sirt1
  - pparab
  - il10
  - kita
  - ngfra
  - nlrp3
  - tnfb
  - il6
  - myd88
  - il15
  - rab1ab
  - akt2
  - pask
  - foxo1a
  - prox1a
  - prdx1
  - prdx2
---
